We are a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around the world.
With integrated research and development, manufacturing, and commercial capabilities as well as strong partnerships with organizations globally, we have developed a diverse pipeline of candidates that have the potential to meaningfully reduce the burden of vaccine-preventable diseases—and to make more diseases preventable. As we focus on delivering vaccines for a healthier world, we remain steadfast in our dedication to both scientific innovation and equitable access.
Our history can be traced back to June 2007, when Dr. Liang, our Chairman and Chief Scientific Officer, established Sichuan Clover to develop a new generation of biologics based on the Trimer-Tag technology platform he invented.